Probenecid; Sulopenem Etzadroxil Patent Expiration
Probenecid; Sulopenem Etzadroxil was first introduced by Iterum Therapeutics Us Ltd
Probenecid; Sulopenem Etzadroxil Patents
Given below is the list of patents protecting Probenecid; Sulopenem Etzadroxil, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Orlynvah | US11478428 | Combinations of beta-lactam compounds and probenecid and uses thereof | Dec 23, 2039 | Iterum Therap |
| Orlynvah | US11554112 | Combinations of β-lactam compounds and probenecid and uses thereof | Apr 01, 2039 | Iterum Therap |
| Orlynvah | US12109197 | Combinations of β-lactam compounds and probenecid and uses thereof | Apr 01, 2039 | Iterum Therap |
| Orlynvah | US7795243 | Penem prodrugs | Jun 03, 2029 | Iterum Therap |
Probenecid; Sulopenem Etzadroxil's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List